<DOC>
	<DOCNO>NCT00899119</DOCNO>
	<brief_summary>RATIONALE : Collecting store stem cell study laboratory may help doctor learn collect stem cell patient undergone treatment Waldenstrom 's macroglobulinemia . PURPOSE : This laboratory study collect stem cell patient Waldenstrom 's macroglobulinemia .</brief_summary>
	<brief_title>Collecting Stem Cells Patients With Waldenstrom 's Macroglobulinemia</brief_title>
	<detailed_description>OBJECTIVES : - Harvest store adequate CD34+ stem cell patient Waldenstrom 's macroglobulinemia ( WM ) potential future use transplantation strategy . - Evaluate ability harvest stem cell therapy WM ( e.g. , fludarabine-based chemotherapy ) evaluate number day adequate harvest . - Collect aliquot stem cell future research analysis part WM database project . OUTLINE : Patients undergo collection autologous stem cell begin day 4 5 continue adequate number stem cell collect . Cells cryopreserved . PROJECTED ACCRUAL : A total 40 patient accrue study .</detailed_description>
	<mesh_term>Waldenstrom Macroglobulinemia</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis Waldenstrom 's macroglobulinemia ( WM ) Less 30 % lymphoplasmacytoid cell bone marrow histopathology Received prior chemotherapy WM PATIENT CHARACTERISTICS : ECOG performance status 01 WBC &gt; 2,000/mm³ Platelet count &gt; 50,000/mm³ LVEF ≥ 50 % No organ dysfunction would preclude future transplantation PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Waldenström macroglobulinemia</keyword>
</DOC>